• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉阻塞中硬化斑块的多模态成像特征。

Multimodal Imaging Characterization of Arteriolosclerotic Plaques in Retinal Vein Occlusion.

出版信息

Ophthalmic Surg Lasers Imaging Retina. 2021 Dec;52(12):650-657. doi: 10.3928/23258160-20211118-01. Epub 2021 Dec 1.

DOI:10.3928/23258160-20211118-01
PMID:34908486
Abstract

BACKGROUND AND OBJECTIVES

To investigate the multimodal imaging features and the clinical associations of arteriolosclerotic plaques in patients with retinal vein occlusion (RVO).

MATERIALS AND METHODS

This was a retrospective case series of patients with RVO. Demographic and clinical characteristics were recorded at the time of RVO for each participant. Best-corrected visual acuity and central macular thickness were collected at baseline and observed for 1 year. Arteriolosclerotic plaques were identified on multimodal imaging, and their imaging features were summarized. Differences in demographic and clinical characteristics between eyes with arteriolosclerotic plaques and those with no arteriolosclerotic plaques were reported.

RESULTS

Seventy-five eyes of 75 patients (39 males; mean age, 72.5 years) were included. Arteriolosclerotic plaques were identified in nine eyes (12%) as segmental, yellow, ill-defined creamy lesions in the arterioles' walls. Baseline macular edema was worse in eyes with arteriolosclerotic plaques than in eyes with no plaques (716.5 μm vs 539.7 μm). Arteriolosclerotic plaques did not interfere with blood flow and regressed in three eyes (33%). Eyes with plaques had worse best-corrected visual acuity ( < .001) and lower central macular thickness ( = .02) at 12 months than did eyes with RVO and no plaques.

CONCLUSIONS

Arteriolosclerotic plaques suggest an ischemic or inflammatory involvement of the arteriolar branches in eyes with RVO and are associated with severe macular damage. .

摘要

背景与目的

本研究旨在探讨视网膜静脉阻塞(RVO)患者的动脉粥样硬化斑块的多模态影像学特征及其临床相关性。

材料与方法

本研究为回顾性病例系列研究,纳入了 RVO 患者。记录每位患者 RVO 时的人口统计学和临床特征。在基线和观察 1 年时收集最佳矫正视力和中心黄斑厚度。在多模态成像上识别动脉粥样硬化斑块,并总结其影像学特征。报告了有动脉粥样硬化斑块的眼与无动脉粥样硬化斑块的眼在人口统计学和临床特征方面的差异。

结果

纳入了 75 例患者的 75 只眼(39 名男性;平均年龄 72.5 岁)。9 只眼(12%)被识别出动脉粥样硬化斑块,表现为动脉壁内节段性、黄色、边界不清的奶油状病变。有斑块的眼在基线时黄斑水肿比无斑块的眼更严重(716.5μm 比 539.7μm)。在 3 只眼中(33%),动脉粥样硬化斑块未干扰血流并消退。有斑块的眼在 12 个月时的最佳矫正视力更差(<0.001),中心黄斑厚度更低(=0.02),与无斑块的 RVO 眼相比。

结论

动脉粥样硬化斑块提示 RVO 眼的小动脉分支存在缺血或炎症受累,并与严重的黄斑损害有关。

相似文献

1
Multimodal Imaging Characterization of Arteriolosclerotic Plaques in Retinal Vein Occlusion.视网膜静脉阻塞中硬化斑块的多模态成像特征。
Ophthalmic Surg Lasers Imaging Retina. 2021 Dec;52(12):650-657. doi: 10.3928/23258160-20211118-01. Epub 2021 Dec 1.
2
Reading speed improvements in retinal vein occlusion after ranibizumab treatment.雷珠单抗治疗视网膜静脉阻塞后阅读速度的提高。
JAMA Ophthalmol. 2013 Jul;131(7):851-6. doi: 10.1001/jamaophthalmol.2013.114.
3
The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.特发性黄斑裂孔手术后玻璃体内注射曲安奈德的疗效观察
Acta Ophthalmol. 2021 Nov;99(7):e1154-e1161. doi: 10.1111/aos.14746. Epub 2021 Jan 9.
4
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.视网膜中央静脉阻塞或半侧视网膜静脉阻塞继发黄斑水肿患者6个月视力和视网膜厚度结果的基线因素:SCORE2研究报告4
JAMA Ophthalmol. 2017 Jun 1;135(6):639-649. doi: 10.1001/jamaophthalmol.2017.1141.
5
Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.在未经治疗的视网膜静脉阻塞所致黄斑水肿患者中使用两个或更多地塞米松玻璃体内植入物:一项回顾性病历审查研究的亚组分析
BMC Ophthalmol. 2015 Sep 4;15:118. doi: 10.1186/s12886-015-0106-z.
6
Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后对视网膜中央的临床、解剖学及电生理评估
Int Ophthalmol. 2016 Feb;36(1):21-36. doi: 10.1007/s10792-015-0066-6. Epub 2015 Mar 29.
7
Efficacy of intravitreal ziv-aflibercept in patients with macular edema following retinal vein occlusion in Korle-Bu Teaching Hospital, Ghana: a retrospective case series.加纳科勒布教学医院视网膜静脉阻塞患者黄斑水肿患者玻璃体内注射 ziv-aflibercept 的疗效:一项回顾性病例系列研究。
Int Ophthalmol. 2021 Jul;41(7):2445-2453. doi: 10.1007/s10792-021-01799-w. Epub 2021 Mar 29.
8
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.视网膜内层紊乱与抗血管内皮生长因子治疗视网膜静脉阻塞继发黄斑水肿的视力反应的相关性研究。
JAMA Ophthalmol. 2019 Jan 1;137(1):38-46. doi: 10.1001/jamaophthalmol.2018.4484.
9
Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion.评估视网膜静脉阻塞继发的非渗出性微囊样黄斑病变。
Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3579-3588. doi: 10.1007/s00417-021-05250-9. Epub 2021 Jun 22.
10
Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.前瞻性研究曲安奈德与贝伐单抗治疗视网膜中央静脉阻塞继发黄斑水肿。
Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

引用本文的文献

1
Near-infrared imaging retinal diagnostic applications-a review.近红外成像在视网膜诊断中的应用——综述
Int Ophthalmol. 2024 Dec 23;45(1):20. doi: 10.1007/s10792-024-03331-2.
2
Multimodal imaging to distinguish microvascular and morphological changes in retinal vein occlusion after intravitreal ranibizumab with or without triamcinolone acetonide injection.多模态成像在玻璃体内雷珠单抗联合或不联合曲安奈德注射治疗视网膜静脉阻塞后的微血管和形态学改变中的鉴别诊断。
BMC Ophthalmol. 2024 Aug 20;24(1):354. doi: 10.1186/s12886-024-03619-y.